Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Veenstra

Showing results (11-20 of 284) with videos related to

Pageof 29
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2012
A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomicsPreeti S Bajaj, David L Veenstra
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2003
Comparative economic analyses of minimally invasive direct coronary artery bypass surgeryDarryl T Gray, David L Veenstra
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2009
The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancerLouis P Garrison, David L Veenstra
The American Journal of Managed Care|July 18, 2003
Managed care in the genomics era: assessing the cost effectiveness of genetic testsMitchell K Higashi, David L Veenstra
Protein Engineering|July 1, 1997
Modeling protein stability: a theoretical analysis of the stability of T4 lysozyme mutantsD L Veenstra, P A Kollman
Journal of Managed Care & Specialty Pharmacy|January 2, 2025
Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line settingEmma Behan, David L Veenstra, Aasthaa Bansal
Journal of the American College of Surgeons|March 22, 2003
A cost-effectiveness analysis of intraoperative cholangiography in the prevention of bile duct injury during laparoscopic cholecystectomyDavid R Flum, Christopher Flowers, David L Veenstra
JAMA|August 18, 1999
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infectionD L Veenstra, S Saint, S D Sullivan
The Pharmacogenomics Journal|May 9, 2007
Ancillary risk information and pharmacogenetic tests: social and policy implicationsN B Henrikson, W Burke, D L Veenstra
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 27, 2001
Trends in expenditures for Medicare liver transplant recipientsJ H Best, D L Veenstra, J Geppert
Pageof 29

Showing results (11-20 of 284) with videos related to

Sort By:
Pageof 29
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2012
A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomicsPreeti S Bajaj, David L Veenstra
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2003
Comparative economic analyses of minimally invasive direct coronary artery bypass surgeryDarryl T Gray, David L Veenstra
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2009
The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancerLouis P Garrison, David L Veenstra
The American Journal of Managed Care|July 18, 2003
Managed care in the genomics era: assessing the cost effectiveness of genetic testsMitchell K Higashi, David L Veenstra
Protein Engineering|July 1, 1997
Modeling protein stability: a theoretical analysis of the stability of T4 lysozyme mutantsD L Veenstra, P A Kollman
Journal of Managed Care & Specialty Pharmacy|January 2, 2025
Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line settingEmma Behan, David L Veenstra, Aasthaa Bansal
Journal of the American College of Surgeons|March 22, 2003
A cost-effectiveness analysis of intraoperative cholangiography in the prevention of bile duct injury during laparoscopic cholecystectomyDavid R Flum, Christopher Flowers, David L Veenstra
JAMA|August 18, 1999
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infectionD L Veenstra, S Saint, S D Sullivan
The Pharmacogenomics Journal|May 9, 2007
Ancillary risk information and pharmacogenetic tests: social and policy implicationsN B Henrikson, W Burke, D L Veenstra
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 27, 2001
Trends in expenditures for Medicare liver transplant recipientsJ H Best, D L Veenstra, J Geppert
Pageof 29